Deng X F, Sculptoreanu A, Mulay S, Peri K G, Li J F, Zheng W H, Chemtob S, Varma D R
Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
J Pharmacol Exp Ther. 1998 Jul;286(1):489-96.
The myocardial effect of alpha-1A adrenoceptor (alpha-1 AR) agonists in neonatal rats are mediated by alpha-1A AR and not by alpha-1B AR, although both receptor subtypes are equally expressed; the functions of alpha-1B AR are not known. Here, we report that alpha-1 B ARs inhibit the activities of alpha-1A ARs in neonatal rat myocardium so that the inactivation of alpha-1 B ARs by chloroethylclonidine (CEC) potentiated the effects of nonselective alpha-1 AR agonist phenylephrine (PE) on myocardial protein synthesis and early gene (c-fos and c-jun) expression. CEC did not modify the hypertrophic effect of angiotensin II. The potentiation of the effects of PE by CEC was associated with a translocation of Ca(++)-dependent protein kinase C (PKC)alpha, which did not occur in the absence of CEC. Alpha-1A AR-selective agonist A61603 was approximately 1000-fold more potent than PE as a positive inotropic agent; it caused the translocation of PKC alpha, which was not affected by CEC. 5-Methylurapidil antagonized the effects of PE and A61603, suggesting that these were mediated via alpha-1A ARs. Alpha-1D AR antagonist BMY 7378 did not modify PE-induced translocation of PKC. CEC potentiated the effects of PE on Ca++ transients in Fura 2-AM-loaded dispersed cardiomyocytes, and this potentiation was prevented by nifedipine. In whole-cell patch-clamp recordings of cultured cardiomyocytes, CEC potentiated the effect of norepinephrine on Ca++ channel currents, which was blocked by 5-methylurapidil. We conclude that alpha-1A ARs are positively and alpha-1B ARs are negatively coupled to nifedipine-sensitive Ca++ channels, possibly via Gi protein, and this antagonistic relationship between alpha-A AR and alpha-1B AR in the neonatal heart might be required physiologically for normal alpha-1 AR-mediated responses and myocardial development.
尽管α-1A和α-1B肾上腺素能受体(α-1 AR)亚型在新生大鼠中表达水平相当,但α-1A AR激动剂对新生大鼠心肌的作用是由α-1A AR介导,而非α-1B AR;α-1B AR的功能尚不清楚。在此,我们报道α-1B AR可抑制新生大鼠心肌中α-1A AR的活性,因此氯乙可乐定(CEC)使α-1B AR失活可增强非选择性α-1 AR激动剂去氧肾上腺素(PE)对心肌蛋白合成和早期基因(c-fos和c-jun)表达的作用。CEC不改变血管紧张素II的肥厚效应。CEC增强PE的作用与钙依赖蛋白激酶C(PKC)α的转位有关,在无CEC时不会发生这种转位。α-1A AR选择性激动剂A61603作为正性肌力药物,其效力比PE强约1000倍;它可引起PKCα的转位,且不受CEC影响。5-甲基尿嘧啶拮抗PE和A61603的作用,提示这些作用是通过α-1A AR介导的。α-1D AR拮抗剂BMY 7378不改变PE诱导的PKC转位。CEC增强PE对用Fura 2-AM负载的分散心肌细胞中Ca++瞬变的作用,且这种增强作用可被硝苯地平阻断。在培养心肌细胞的全细胞膜片钳记录中,CEC增强去甲肾上腺素对Ca++通道电流的作用,该作用可被5-甲基尿嘧啶阻断。我们得出结论,α-1A AR与硝苯地平敏感的Ca++通道呈正偶联,而α-1B AR与该通道呈负偶联,可能是通过Gi蛋白介导,新生心脏中α-1A AR和α-1B AR之间的这种拮抗关系在生理上可能是正常α-1 AR介导的反应和心肌发育所必需的。